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In spinal muscular atrophy, a neurodegenerative dis-
ease caused by ubiquitous deficiency in the survival
motor neuron (SMN) protein, sensory-motor synap-
tic dysfunction and increased excitability precede
motor neuron (MN) loss. Whether central synaptic
dysfunction and MN hyperexcitability are cell-auton-
omous events or they contribute to MN death is un-
known. We addressed these issues using a stem-
cell-based model of the motor circuit consisting of
MNs and both excitatory and inhibitory interneurons
(INs) in which SMN protein levels are selectively
depleted. We show that SMN deficiency induces
selective MN death through cell-autonomous mech-
anisms, while hyperexcitability is a non-cell-autono-
mous response of MNs to defects in pre-motor INs,
leading to loss of glutamatergic synapses and
reduced excitation. Findings from our in vitro model
suggest that dysfunction and loss of MNs result
from differential effects of SMN deficiency in distinct
neurons of the motor circuit and that hyperexcitabil-
ity does not trigger MN death.
INTRODUCTION
Movement is a fundamental behavior produced by contraction of
muscles in response to motor neuron (MN) activity. This requires
the finely tuned balance of excitatory and inhibitory synaptic
drive onto spinal MNs, which is controlled by a variety of synaptic
inputs from descending motor pathways, proprioceptive sen-
sory neurons, and local interneurons (INs) of the spinal motor cir-
cuit (Arber, 2012). Perturbations in any one element of the motor
circuit can have deleterious effects on motor output and are
often associated with human disease. Accordingly, degenera-1416 Cell Reports 16, 1416–1430, August 2, 2016 ª 2016 The Author
This is an open access article under the CC BY-NC-ND license (http://tion of neurons in brain regions that have modulatory roles in
the control of movement underlies motor symptoms in Parkin-
son’s disease (PD) and Huntington’s disease (HD) (Blesa and
Przedborski, 2014; Yasuda et al., 2013), while loss of spinal
MNs characterizes amyotrophic lateral sclerosis (ALS) (Saxena
and Caroni, 2011) and spinal muscular atrophy (SMA) (Tisdale
and Pellizzoni, 2015), among other MN disorders. Although the
loss of specific neuronal populations is a hallmark of neurode-
generative diseases and the functional properties of vulnerable
neurons are often altered prior to death, the basis for the selec-
tive vulnerability and the link between dysfunction and death of
vulnerable neurons are poorly understood.
In recent years, increasing attention has been given to the pos-
sibility that synaptic dysfunction within neural networks is an
early, initiating event of disease pathogenesis possibly leading
to neuronal death (Caviness, 2014; Li et al., 2003; Marcello
et al., 2012; Palop and Mucke, 2010). For instance, alterations
of basal ganglia circuitry that lead to deficits in motor control
and cognitive processes precede loss of substantia nigra neu-
rons in PD (Meredith and Kang, 2006; M€uller et al., 2013) and
striatal spiny neurons in HD (Mazarakis et al., 2005; Milnerwood
and Raymond, 2007; Usdin et al., 1999), respectively. These and
other findings support a network dysfunction model in which
disruption of neuronal circuits might be a critical component to
disease progression prior to neuronal loss (Palop et al., 2006).
In this context, SMA, the most common inherited cause of infant
mortality, has recently emerged as a model to investigate the
impact of circuit dysfunction in neurodegenerative disease
(Mentis et al., 2011; Imlach et al., 2012; Lotti et al., 2012; Roselli
and Caroni, 2012; Tisdale and Pellizzoni, 2015).
SMA is caused by a ubiquitous deficiency in the survival motor
neuron (SMN) protein and is characterized by loss of MNs and
skeletal muscle atrophy (Tisdale and Pellizzoni, 2015). Through
selective depletion and restoration of SMN in specific cell types,
several studies revealed that MN death is a cell-autonomous pro-
cess induced by SMNdeficiency, which alone cannot account for
the SMA phenotype (Gogliotti et al., 2012; Martinez et al., 2012;s.
creativecommons.org/licenses/by-nc-nd/4.0/).
McGovern et al., 2015). Importantly, dysfunction in other neurons
is emerging as an important determinant of motor system pathol-
ogy in SMA models (Mentis et al., 2011; Imlach et al., 2012;
McGovern et al., 2015), while intrinsic muscle deficits do not
play a major role (Iyer et al., 2015). In SMAmice, there is a reduc-
tion in excitatory, but not inhibitory, inputs on SMA MNs (Ling
et al., 2010;Mentis et al., 2011), and these central synaptic abnor-
malities are associated with altered sensory-motor neurotrans-
missionand increased intrinsic excitability ofMNs,whichprecede
death of vulnerable MNs (Mentis et al., 2011). Interestingly,
increased neuronal excitability is a pathogenic feature common
to several neurodegenerative diseases (Bories et al., 2007; Bu-
sche et al., 2008; Chan et al., 2007; Palop et al., 2007; Zeron
et al., 2002). For instance, compromised afferent connectivity
and increased excitability are observed in striatal neurons of HD
mouse models (Klapstein et al., 2001), and MN hyperexcitability
in mouse models (Bories et al., 2007; Leroy et al., 2014; Quinlan
et al., 2011) and cortical hyperexcitability in patients (Vucic
et al., 2008) have been linked to neuronal dysfunction in ALS.
However, whether hyperexcitability plays a direct causal role in
the degeneration of vulnerable neurons is yet to be established,
and it remains possible that increased neuronal excitability repre-
sents a neuroprotective response to degenerative processes
driven by network dysfunction (Palop et al., 2006; Saxena and
Caroni, 2011). Understanding the relationships among neural cir-
cuit abnormalities, synaptic dysfunction, and selective neuronal
death may therefore elucidate neurodegenerative disease mech-
anisms and reveal therapeutic strategies.
Here, we sought to define the cell-autonomous and non-cell-
autonomous requirements of SMN for the survival and function
ofMNswithin themotor circuit. To do so,weestablished a simpli-
fied in vitro model of the motor circuit comprising MNs and both
excitatory and inhibitory INs differentiated from mouse embry-
onic stem cells (ESCs) in which SMN levels can be selectively
regulated by RNAi. This system not only recapitulated key path-
ological changes induced by SMN deficiency in vivo, such as
membrane hyperexcitability and death of SMA MNs, but also
enabled us to determine the cellular basis of these phenotypes.
Our findings indicate that hyperexcitability and death of SMN-
deficient MNs are independent events, resulting from the differ-
ential effects of SMN deficiency in distinct neurons of the motor
circuit. Furthermore, they implicate altered balance of excitation
to inhibition frompremotor INs in theSMN-dependent changesof
MN excitability. Beyond establishing a stem cell-based platform
for the study of SMA disease mechanisms, these results shed
light on the origin and causal sequence of events underlying mo-
tor circuit dysfunction andMNdeath induced bySMNdeficiency.
RESULTS
Development of ESCs with Inducible SMN Knockdown
To investigate the effects of SMN deficiency in MNs, we gener-
ated a cellularmodel with drug-inducible, RNAi-mediated knock-
down of endogenous Smn in mouse ESCs. First, ES(Hb9::GFP)
cells (Wichterle et al., 2002) were transduced with a lentivirus ex-
pressing the tetracycline-regulated repressor protein (TetR) and
the neomycin resistance gene under the control of the constitu-
tively active PGK promoter (Figure 1A). A neomycin-resistantclone with high TetR expression was isolated and then trans-
duced with a lentivirus that expresses a short hairpin RNA
(shRNA) against mouse Smn mRNA under the control of a modi-
fied H1 promoter containing the Tet operator (TO) sequences as
well as the puromycin resistance gene driven by the PGK pro-
moter (Figure 1A), which was followed by puromycin selection
to isolate clonal ES(Hb9::GFP)-SmnRNAi cells. The constitutively
expressed TetR protein binds to the TO sequences and re-
presses shRNA expression. Addition of the tetracycline analog
doxycycline (Dox) to the growthmedia relieves TetRprotein bind-
ing and induces Smn shRNA expression (Lotti et al., 2012).
RNA and protein analysis from control (wild-type [WT]) and
SmnRNAi (RNAi) ESCs cultured in the presence or absence of
Dox for 4 days showed a strong decrease in SmnmRNAand pro-
tein levels in Dox-treated relative to untreated RNAi cells, while
Dox treatment had no effect on Smn levels in WT cells (Figures
1B and 1C). Importantly, following ES-SmnRNAi differentiation
into MNs, Dox treatment for 5 days induced a decrease in Smn
mRNA and protein to 10% of normal levels (Figures 1D and
1E), which is comparable to SMN expression in tissues of severe
SMA mice (Gabanella et al., 2007).
To control for potential shRNA off-target effects, we generated
an additional cell line ES(Hb9::GFP)-SMN/SmnRNAi by trans-
ducing ES-SmnRNAi cells with a lentivector expressing epitope-
tagged human SMN (hSMN) under the control of the ubiquitous
PGK promoter and the hygromycin resistance gene driven by the
SV40 promoter (Figure S1A). qRT-PCR andwestern blot analysis
of both ES and ES-derived MNs from this cell line revealed both
hSMN expression and a reduction of endogenous Smn similar to
that in the parental SmnRNAi cell line following Dox treatment
(Figures S1B–S1E). Furthermore, since the shRNA specifically
targets mouse, but not human, SMN (Lotti et al., 2012), hSMN
was unaffected by Dox treatment and was found to accumulate
to 15%–20% the levels of endogenous Smn (Figures S1C and
S1E). Importantly, ES(Hb9::GFP) cells express GFP driven by the
Hb9 promoter following directed differentiation into MNs (Wich-
terle et al., 2002), and both SmnRNAi and SMN/SmnRNAi ESCs
retained the ability to differentiate into MNs with an efficiency
similar to the parental WT cell line as determined by fluores-
cence-activated cell sorting (FACS) analysis (Figure S1F).
In summary, we established ESC lines with drug-inducible
knockdown of endogenous Smn. The regulated expression of
Smn combinedwith theMN-specific expression of GFP provides
a powerful platform to study the effects of SMN deficiency on
MN survival and function.
Smn Deficiency Leads to Cell-Autonomous Death
of MNs
SinceMN loss is a hallmark in SMA (Tisdale and Pellizzoni, 2015),
we investigated whether Smn deficiency induces death of
MNs in our model system by comparing the survival of MNs
differentiated fromWT andRNAi ESCs. To do so, ES-MNs disso-
ciated from embryoid bodies (EBs), which contain 25% MNs
together with both neuronal and non-neuronal cells (Figure S1F),
were plated into 96-well plates and cultured in the presence
or absence of Dox for up to 5 days. MN number was deter-
mined daily using automated, high-throughput image collection
of complete wells (Figure 1F) followed by analysis with theCell Reports 16, 1416–1430, August 2, 2016 1417
Figure 1. Smn Deficiency Induces MN Death through Cell-Autono-
mous Mechanisms
(A) Schematic representation of the lentiviral vectors used to generate the
ES(Hb9:GFP)-SmnRNAi cell line.
(B) qRT-PCR analysis of SmnmRNA levels in WT and RNAi ESCs cultured with
and without doxycycline (Dox) for 4 days. RNA levels in Dox-treated cells are
expressed relative to those in untreated cells. Data represent mean and SEM
from independent experiments (n = 3).
(C) Western blot analysis of Smn protein levels in WT and RNAi ESCs cultured
with and without Dox for 4 days. A 2-fold serial dilution of WT ESC extract is
analyzed on the left.
1418 Cell Reports 16, 1416–1430, August 2, 2016MetaMorph software to selectively identify and count the num-
ber of GFP+ cells (Figure 1G). While Dox treatment had no effect
on the survival of MNs differentiated fromWT ESCs, Dox-treated
Smn-deficient MNs differentiated from RNAi ESCs exhibited
a significant time-dependent decrease in survival relative to
untreated MNs with normal Smn levels (Figure 1H). Importantly,
Dox-treatedMNs differentiated from ES-SMN/SmnRNAi cells had
a survival comparable to that of WT MNs (Figure 1H), indicating
that the relatively low levels of hSMN expression in ES-SMN/
SmnRNAi cells were sufficient to correct the survival deficits
induced by Smn deficiency in ES-MNs and that these deficits
are SMN dependent. While seemingly surprising, the restoration
of ES-MN survival by a 2-fold increase in SMN levels is consis-
tent with in vivo studies showing that SMN-dependent pheno-
types are strongly dependent on the reduction of SMN protein
below a critical threshold and that a small increase in SMN
dosage can have a dramatic biological impact as indicated by
the analysis of Smn knockout mice harboring an allelic series
of hypomorphic SMN2 genes (Osborne et al., 2012).
Next, we analyzed IN survival by counting the number of Tuj1+/
GFP neurons differentiated from RNAi ESCs (Figure S1G) and
found no significant loss of SMN-deficient INs relative to controls
after 5 days in culture (Figure S1H), highlighting the selectivity
of the effects of SMN deficiency on MN survival. Lastly, we
investigated whether the effect of SMN deficiency on ES-MN
survival was mediated by cell-autonomous or non-cell-autono-
mous mechanisms. To do so, we carried out survival analysis
of GFP+ MNs differentiated from either WT or RNAi ESCs
following their FACS purification to >95% purity (Figures S1I
and S1J). Smn deficiency induced death of purified MNs to a
rate and extent similar to that of MNs inmixed cultures with other
neurons and non-neuronal cells (Figure 1I), while FACS-purified
Dox-treated MNs differentiated from ES-SMN/SmnRNAi cells
had a survival comparable to that of WT MNs (Figure 1I), indi-
cating that hSMN expression in purified SMN-deficient MNs
rescued neuronal death.
Together, these results demonstrate that our stem cell model
recapitulates the selective death of MNs induced by Smn(D) qRT-PCR analysis of Smn mRNA levels in FACS-purified MNs differenti-
ated from WT and RNAi ESCs cultured with and without Dox for 5 days. RNA
levels in Dox-treated cells are expressed relative to those in untreated cells.
Data represent mean and SEM from independent experiments (n = 3).
(E) Western blot analysis of Smn protein levels in mixed cultures of ES-MNs
cultured with andwithout Dox for 5 days after differentiation fromWT and RNAi
ESCs. A 2-fold serial dilution of the extract from WT ES-MNs is analyzed on
the left.
(F) Representative 96-well image of GFP+MNs differentiated fromWT ESCs at
5 DIV. Scale bar, 800 mm.
(G)MetaMorph software analysis of GFP+MNs from the image in (F). Scale bar,
800 mm.
(H) Survival analysis of GFP+ MNs in mixed cultures following differentiation
from WT, RNAi, and RNAi + SMN ESCs cultured with and without Dox.
Normalized data of Dox-treated relative to untreated cells are shown as mean
and SEM from independent experiments (nR 6).
(I) Survival analysis of FACS purified GFP+ MNs following differentiation from
WT, RNAi, and RNAi + SMN ESCs cultured with and without Dox. Normalized
data of Dox-treated relative to untreated cells are shown as mean and SEM
from independent experiments (n = 3).
See also Figure S1.
deficiency, which is a key feature of the disease in both humans
and mouse models. They further indicate that cell-autonomous
mechanisms are responsible for the death of Smn-deficient
MNs in vitro.
Smn Deficiency Induces MN Hyperexcitability by Non-
Cell-Autonomous Mechanisms
Increased membrane excitability is an early physiological signa-
ture of dysfunction that precedes MN death in mouse models of
SMA (Mentis et al., 2011). However, the cellular basis of this
physiological perturbation and its relationship with MN death
are unknown. To address these issues, we used whole-cell
patch-clamp recordings to study the functional characteristics
of ES-derived MNs with either normal or reduced levels of
Smn. MNs differentiated from WT and RNAi ESCs were cultured
in the presence or absence of Dox for 5 days and then visually
targeted based on GFP expression for intracellular recordings,
after which they were filled with a fluorescent dye for post
hoc morphological analysis (Figure 2A). Remarkably, while the
resting membrane potential of MNs did not reveal any significant
differences between groups (Table S1), two passive membrane
properties of input resistance and time constant were signifi-
cantly increased in Dox-treated Smn-deficient MNs relative to
untreated MNs differentiated from RNAi ESCs (Figures 2B and
2C). Dox treatment had no effect on the intrinsic membrane
properties of MNs differentiated fromWT ESCs that have normal
Smn levels (Figures S2A–S2C), and hSMN expression corrected
the changes in both input resistance and time constant in
Smn-deficient MNs differentiated from ES-SMN/SmnRNAi cells
(Figures S2D–S2F), demonstrating that these physiological alter-
ations are SMN dependent.
To determine if increased excitability reflects intrinsic, cell-
autonomous changes induced by SMN deficiency in MNs,
we performed electrophysiological recordings in FACS-purified
MNs differentiated from RNAi ESCs (Figures S1I and S1J).
We found that purified, Smn-deficient MNs did not exhibit
any significant differences in either input resistance or time
constant or changes in resting membrane potential compared
to controls with normal Smn levels (Figures 2D–2F; Table S1),
indicating that hyperexcitability is independent of Smn reduc-
tion in MNs.
Together, these results demonstrate that Smn deficiency
alters the intrinsic membrane properties of ES-derived MNs
in vitro, inducing a state of hyperexcitability akin to the functional
changes observed in SMA MNs in vivo (Mentis et al., 2011).
Moreover, they indicate that Smn deficiency induces MN hyper-
excitability through non-cell-autonomous mechanisms that are
likely distinct from the cell-autonomous mechanisms that result
in MN death.
SMN Deficiency Does Not Alter the Somatodendritic
Area of MNs
Next, we sought to investigate the mechanisms responsible for
the MN excitability changes induced by SMN deficiency. Soma
size, dendritic tree area, and specific membrane resistivity are
among the key parameters governing the intrinsic membrane
properties of MNs (Kernell, 1966; Mentis et al., 2007). Therefore,
we first investigated if changes in hyperexcitability could be dueto a Smn-dependent reduction in the somatodendritic area of
MNs. To do so, we acquired confocal images of intracellularly
filled MNs following electrophysiological recordings, which we
reconstructed and analyzed using Neurolucida software (Figures
3A and 3C). Tracing analysis revealed no changes in total den-
dritic area, length or number of primary dendrites, and number
of dendritic ends between Smn-deficient and control MNs in
mixed (Figures 3B and S3A) or FACS-purified (Figures 3D and
S3B) cultures. Additionally, there was no difference in transverse
soma area between the two groups (Figures 3B and 3D). The lack
of morphological changes in dendritic tree and soma area was
also consistent with the observation that the capacitance, a
physiological readout of membrane area, was not significantly
different between control and Smn-deficient MNs (Figures 3B
and 3D; Table S1). Notably, however, FACSMNs possess a den-
dritic tree of much lower complexity compared to MNs in mixed
cultures (Figure 3). This strong reduction in dendritic complexity
is not dependent on SMN expression or due to the FACS proce-
dures; rather, it is the effect of MNs being cultured in isolation
(see also Figures S5C and S5D). Together, these results demon-
strate that morphological changes in the somatodendritic area
of MNs do not contribute to their increased excitability upon
SMN depletion.
Development of ESC Lines for the Purification of INs
with Inducible SMN Knockdown
To investigate the possibility that MN hyperexcitability repre-
sents a response to dysfunction of Smn-deficient premotor
INs, we developed a purified co-culture system in which the
effects of selective reduction of Smn in either MNs or INs could
be specifically dissected.
First, we modified our mouse ESC lines to fluorescently label
and sort INs following neuronal differentiation. TetR-expressing
WT and RNAi ES(Hb9::GFP) cells were transduced with a lentivi-
ral construct expressing mCherry under the control of the pan-
neuronal mouse Synapsin 1 (Syn1) promoter, which has been
shown to drive efficient and specific expression of transgenes
in neurons (K€ugler et al., 2001), and the hygromycin resistance
gene expressed from the SV40 promoter for antibiotic selection
(Figure 4A). To validate the specificity of mCherry expression in
neurons, retinoic acid (RA) was used to differentiate WT and
RNAi ES(Hb9::GFP; Syn::mCherry) cell lines to neurons, which
we then immunostained with the pan-neuronal Tuj1 antibody
(Figure 4B). We found that >95% of Tuj1+ neurons co-expressed
mCherry, which had marginal, if any, expression in non-neuronal
cells (Figure 4C).
Next, we cultured WT and RNAi ES(Hb9::GFP; Syn::mCherry)
cells for 5 days in the presence or absence of Dox and found that
Dox treatment induced a strong reduction in both Smn mRNA
and protein levels in RNAi, but not WT cells (Figures 4D and
4E). Further, a similar Dox-dependent Smn knockdown was
also seen after neuronal differentiation of RNAi, but not WT
ES(Hb9::GFP; Syn::mCherry) cells (Figures 4F and 4G). Thus,
both the specificity and extent of Smn knockdown was analo-
gous to that observed in their respective parental cell lines
(compare Figures 1B–1E and 4D–4G).
Directed differentiation of ESCs in the presence of RA can
yield spinal INs, the exact identity of which has not beenCell Reports 16, 1416–1430, August 2, 2016 1419
Figure 2. Smn Deficiency Induces MN Hyperexcitability Non-cell Autonomously
(A) Representative images of intracellularly filled control (Dox) and Smn-deficient (+Dox) MNs differentiated from RNAi ESCs and cultured under mixed con-
ditions for 5 days. Top: Alexa Fluor 555 fill in red. Bottom: merged with GFP in green. Scale bar, 20mm.
(B) Superimposed membrane responses (upper traces) following current injection (lower traces) in control and Smn-deficient MNs as in A. Scale bars, 20 mV,
40 pA, 40 ms.
(C) Current/voltage relationships for the MNs shown in (B) (Input resistance: Dox = 534 MU, +Dox = 782 MU) and averages for input resistance (Rin) and time
constant (t) of control (n = 15) and Smn-deficient (n = 14) MNs at 5 DIV.
(D) Representative images of intracellularly filled control (Dox) and Smn-deficient (+Dox) MNs differentiated from RNAi ESCs and cultured for 5 days after FACS
purification. Top: Alexa Fluor 555 fill in red. Bottom: merged with GFP in green. Scale bar, 20 mm.
(E) Superimposed membrane responses (upper traces) following current injection (lower traces) of control and Smn-deficient FACS purified MNs as in (D). Scale
bars, 20 mV, 40 pA, 40 ms.
(F) Current/voltage relationships for the two FACS purifiedMNs shown in (E) (input resistance:Dox = 582MU, +Dox = 598MU) and average input resistance and
time constant of FACS-purified control (n = 15) and Smn-deficient (n = 15) MNs at 5 DIV.
See also Figure S2.established. Since spinal motor circuits in vivo comprise both
excitatory and inhibitory inputs that converge onto MNs to
modulate their function (Arber, 2012), we investigated the1420 Cell Reports 16, 1416–1430, August 2, 2016neurotransmitter identity of INs differentiated from mouse
ESCs. Importantly, mCherry+ INs can be differentiated from
ES(Hb9::GFP; Syn::mCherry) cells with high efficiency in the
Figure 3. Smn Deficiency Does Not Alter the Somatodendritic Area of MNs
(A) Single-plane confocal images of Alexa Fluor 555 intracellularly filled control (Dox) and Smn-deficient (+Dox) MNs differentiated from RNAi ESCs in mixed
cultures at 5 DIV (top panels) and Neurolucida reconstructions of their dendritic trees (bottom panels).
(B) Quantification of dendritic tree, soma area, and capacitance of control (n = 13) and Smn-deficient (n = 12) MNs in mixed cultures at 5 DIV.
(C) Single-plane confocal images of Alexa Fluor 555 intracellularly filled control (Dox) and Smn-deficient (+Dox) FACS purified MNs differentiated from RNAi
ESCs at 5 DIV (top panels) and Neurolucida reconstruction of their dendritic trees (bottom panels).
(D) Quantification of dendritic tree, soma area, and capacitance of control (n = 9) and Smn-deficient (n = 7) MNs in FACS purified cultures at 5 DIV. Arrows indicate
putative axons. Scale bars, 40mm.
See also Figure S3.presence of RA and isolated by FACS to >95% purity and
with essentially no MN contamination (Figures S4A–S4D). We
performed qRT-PCR experiments on RNA extracted from ES-
derived, FACS-purified INs and MNs to measure the relative
enrichment of all three glutamatergic vesicular transporters
(VGluT1, 2, and 3), the vesicular GABA transporter (VGAT),
the neuronal glycine transporter (GlyT2), and the cholinergic
transporter (VAChT). We also monitored expression of the pan-
neuronal markers Syn1 and synaptophysin (Syp) as well as
the MN-specific markers Hb9 and choline acetyl transferase
(ChAT). We found that purified INs and MNs express similar
levels of Syn1 and Syp (Figure S4E), while the cholinergic
markers VAChT and ChAT as well as the MN-specific transcrip-
tion factor Hb9 are highly expressed in MNs, but not in INs (Fig-
ure S4F). Conversely, INs express significantly higher levels of
VGluT2, VGAT, and GlyT2 mRNAs relative to MNs (Figure S4G).
qRT-PCR also indicated that VGluT1 and VGluT3mRNAs as wellas dopaminergic and serotonergic markers are not expressed in
INs (Figure S4G; data not shown).
In summary, we established an ESC-based system to fluores-
cently identify and efficiently purify excitatory (VGluT2) and inhib-
itory (VGAT and GlyT2) INs with regulated knockdown of SMN.
Smn Deficiency in Pre-motor INs Induces MN
Hyperexcitability
To determine the cellular basis of MN dysfunction induced
by SMN deficiency, we developed a simplified in vitro model of
the motor circuit that took advantage of our ability to isolate
ESC-derived MNs and INs and to knockdown Smn selectively
in either neuronal type. We co-cultured FACS-purified GFP+
MNs derived from WT or RNAi ES(Hb9::GFP) cells with
FACS-purified mCherry+/GFP INs derived from WT or RNAi
ES(Hb9::GFP; Syn::mCherry) cells (Figure 5A). MNs and INs
were co-plated at a 1 to 5 ratio (the same found inmixed cultures)Cell Reports 16, 1416–1430, August 2, 2016 1421
Figure 4. Development of ESC Lines for the Purification of INs with Inducible Smn Knockdown
(A) Schematic representation of the lentiviral vector used to generate WT and RNAi ES(Hb9::GFP;Syn::mCherry) cell lines.
(B) Representative images of ES(Hb9::GFP;Syn::mCherry)-derived neuronal cultures expressing mCherry (red) and stained with Tuj1 (green) and DAPI (blue) at
5 DIV. Scale bar, 100 mm.
(C) Quantification of mCherry+/Tuj1+ INs in neuronal cultures differentiated from WT and RNAi ES(Hb9::GFP;Syn::mCherry) cells as in (B) (nR 3).
(D) qRT-PCR analysis of SmnmRNA levels inWT and RNAi ES(Hb9::GFP;Syn::mCherry) cells cultured with and without Dox for 4 days. RNA levels in Dox-treated
cells are expressed relative to those in untreated cells. Data represent mean and SEM from independent experiments (n = 3).
(E) Western blot analysis of Smn protein levels in WT and RNAi ESCs cultured as in (D). A 2-fold serial dilution of WT ESC extract is analyzed on the left.
(F) qRT-PCR analysis of Smn mRNA levels in FACS-purified INs differentiated from WT and RNAi ESCs cultured with and without Dox for 5 days. RNA levels in
Dox-treated cells are expressed relative to those in untreated cells. Data represent mean and SEM from independent experiments (n = 3).
(G) Western blot analysis of Smn protein levels in mixed cultures of ES-INs cultured with and without Dox for 5 days after differentiation fromWT and RNAi ESCs.
A 2-fold serial dilution of the extract from WT ES-INs is analyzed on the left.
See also Figure S4.
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Figure 5. Smn Deficiency in Pre-motor INs Induces MN Hyperexcitability
(A) Schematic representation of the design for co-culture experiments with FACS-purified MNs and INs.
(B) Representative confocal images of an intracellularly filled (blue), GFP+ (green) MN co-cultured with mCherry+ (red) INs. Scale bar, 50mm.
(legend continued on next page)
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and cultured for 5 days in the presence of Dox prior to electro-
physiological analysis (Figures 5A and 5B). Western blot analysis
confirmed robust, Dox-dependent Smn knockdown in FACS-
purified MNs and INs differentiated from RNAi, but not WT
ESC lines, under these experimental conditions (Figure S5A).
We investigated the Smn-dependent functional changes in
MNs co-cultured with INs in the following four different combina-
tions (Figure 5A): (1) WTMNswithWT INs, (2) Smn-deficient MNs
with Smn-deficient INs, (3) Smn-deficient MNs with WT INs, and
(4) WT MNs with Smn-deficient INs. Following patch-clamp
studies to determine their physiological parameters, MNs were
subsequently filled for morphological studies (Figure 5B) and
tracing analysis using Neurolucida revealed that the extent and
complexity of the dendritic arborization of FACS-purified MNs
co-culturedwith INs issimilar to that ofMNs inmixedcultures (Fig-
ures S5C and S5D). WhileMN resting potential was unchanged in
all combinations (Table S1), analysis of co-cultures of Smn-defi-
cient MNs and INs compared to WT co-cultures revealed an in-
crease in input resistance and time constant of MNs (Figures 5C
and 5D) similar to that found in mixed cultures (see also Figures
2B and 2C). Next, we investigated the intrinsic properties of
Smn-deficient MNs co-plated with WT INs and found no signifi-
cant difference in either input resistance or time constant (Figures
5Cand5D). Inmarkedcontrast, the intrinsic properties ofWTMNs
co-plated with Smn-deficient INs were significantly altered as
indicated by the increases in both input resistance and time con-
stant (Figures 5C and 5D). These results demonstrate that Smn
deficiency in INs induces non-cell-autonomous dysfunction of
MNs by increasing their intrinsic membrane excitability.
Smn Deficiency in INs Leads to Loss of Excitatory
Synapses onto MNs
The intrinsic mechanisms by which SMN-deficient INs elicit hy-
perexcitability of MNs is unknown. Consistent with the loss of
excitatory glutamatergic synapses onto MNs observed in SMA
mice (Ling et al., 2010; Mentis et al., 2011), one possibility is
that decreased excitatory presynaptic input from INs may
contribute to MN dysfunction in our model of the motor circuit.
To address this, we investigated the effects of Smn depletion
on synaptic inputs from pre-motor INs ontoMN somata and den-
drites by immunostaining of synapses that impinge on intracellu-
larly filled MNs described in Figure 5. Synapses were identified
by immunoreactivity against the pan-synaptic marker Syp and
either VGluT2 to label excitatory synapses (Figures 6A and 6B)
or VGAT to label inhibitory GABAergic synapses (Figures 6D
and 6E), while we were unable to detect GlyT2 synapses with
available antibodies.
To further validate the identity of Syp+ puncta as bona fide syn-
aptic connections, we used antibodies against PSD95 and ge-
phyrin to investigate post-synaptic specialization of excitatory
and inhibitory synapses, respectively. As expected, we found(C) Superimposed membrane responses (top traces) following current injection
combinations. Scale bars, 20 mV, 40 pA, 40 ms. For ease of comparison, in each
wild-type (WT) conditions.
(D) Mean input resistance (Rin) and time constant (t) of MNs recorded in the four d
MN(RNAi) + IN(WT), n = 18; MN(WT) + IN(RNAi), n = 17.
See also Figure S5.
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on somata and dendrites of MNs (Figures S6A and S6B). Greater
than 90% of Syp+ boutons onto MNs had a post-synaptic
specialization with 70% being opposed to PSD95 and 20%
to gephyrin (Figure S6C). In addition, VGluT2+ boutons are
opposed to PSD95, but not to gephyrin (data not shown),
demonstrating proper specificity in the specialization of excit-
atory synapses. Lastly, we investigated the ultra-structural fea-
tures of the synapses established in co-cultures of MNs and
INs by electron microscopy (EM) analysis of intracellularly filled
MNs at 5 days in vitro (DIV) (Figures S6D–S6G). The EM showed
that somata and dendrites of MNs receive presynaptic boutons
containing neurotransmitter vesicles, mitochondria, and active
zones (Figure S6G), further corroborating the formation of proper
synaptic connections in our in vitro model of the motor circuit.
In cultures with normal levels of SMN, VGluT2+ excitatory syn-
apses constituted 40% and 30% of the total number of syn-
apses, respectively, on MN soma and dendrites (Figure 6C).
Importantly, SMN deficiency in both INs and MNs caused a
80% reduction of VGluT2 synapses on soma and70% reduc-
tion on dendrites of MNs (Figures 6A–6C). In contrast, the num-
ber of GABAergic synapses, which constitute 15% of the total
number of synapses onto MNs, was not significantly altered by
Smn depletion (Figures 6D–6F), demonstrating the specificity
of the effects for excitatory synapses. Furthermore, qRT-PCR
experiments revealed that SMN deficiency does not alter the
expression of VGluT2 as well as VGAT, GlyT2, and Syn1 mRNAs
in purified INs (Figure S5B). Thus, the SMN-dependent reduction
in VGluT2 synapses cannot be attributed to either downregula-
tion of VGluT2 mRNA expression or death of INs.
Next, we investigated whether the selective loss of glutama-
tergic synapses was dependent on Smn deficiency in MNs,
INs, or both. We quantified the synaptic coverage of VGluT2 syn-
apses in co-cultures of Smn-deficient MNs with WT INs and vice
versa. Remarkably, we found that the number of VGluT2 synap-
ses on both somata and dendrites of MNs was decreased when
Smn-deficient INs were co-cultured with normal MNs, while it
was not affected when normal INs were co-cultured with Smn-
deficient MNs (Figure 6C). Therefore, the reduction in VGluT2
synapses was specifically due to the effects of Smn deficiency
in INs, but not MNs. Collectively, these results identify the loss
of VGluT2 synapses on MNs as an intrinsic defect induced by
SMN deficiency in excitatory INs, which in turn may trigger
homeostatic changes of MN excitability through a reduction in
the excitatory drive.
Block of Excitatory Neurotransmission Induces
Hyperexcitability, but Not Death, of MNs
Our findings implicate dysregulation of synaptic activity of excit-
atory pre-motor INs as a non-cell-autonomous mechanism
contributing to the increased excitability of MNs induced by(bottom traces) and current/voltage relationships for MNs recorded in all four
graph the black dotted line represents the current/voltage relationship under
ifferent combinations: MN(WT) + IN(WT), n = 12; MN(RNAi) + IN(RNAi), n = 13;
(legend on next page)
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SMN deficiency. Therefore, we used pharmacological assays to
investigate whether altered excitatory synaptic drive can modify
the intrinsicmembrane excitability ofMNs in vitro. First, we chron-
ically applied tetrodotoxin (TTX) in mixed cultures of ES-derived
WT MNs to inhibit the firing of action potentials in neurons and
to study the effect of global silencing of neuronal activity. Patch-
clamp recordings revealed that in response to TTX, WT MNs
exhibited a25% increase in both input resistance and time con-
stant at 5 DIV (Figures 7A and 7B), while resting potential, soma
area, and capacitancewere unchanged (Table S1). TTX treatment
did not cause a further increase in the input resistance of Smn-
deficient MNs (Figure S7). Together, these findings reveal that
TTX-dependent silencing of synaptic transmission leads to an
activity-dependent increase in excitability of WT MNs.
Next, we determined the relative contribution of excitatory,
inhibitory, andcholinergic synapticdrive toMNexcitability through
selective neurotransmission blockade. Mixed cultures of ES-MNs
were treated daily with either glutamatergic (NBQX and APV),
cholinergic (atropine, mecamylamine, and dHBE), glycinergic
(strychnine), or GABAergic (bicuculline) receptor blockers, and
recordings were performed at 5 DIV in the presence of these
blockers. Strikingly, while blocking cholinergic or inhibitory neuro-
transmission had no effect on the intrinsic properties of MNs (Fig-
ures7Aand7B), glutamatergic receptorsblockade increasedboth
input resistance and time constant of WT ES-MNs to an extent
comparable to that of chronic TTX treatment (Figures 7A and 7B;
Table S1). No changes in resting potential, soma area, or capaci-
tance were found in any of these conditions (Table S1).
Lastly, we investigated the effect of treatment with neurotrans-
mitter blockers on MN survival. Time-course analysis of MN sur-
vival in the presence of vehicle or pharmacological blockers
at the same concentrations used for electrophysiology studies
showed that neither TTX nor any of the neurotransmitter receptor
blockers enhanced MN loss relative to vehicle-treated controls
(Figure 7C).
Collectively, these results reveal that excitatory glutamatergic
neurotransmission plays a key role in governing the intrinsic
properties of MNs and that its reduction phenocopies the
increased excitability induced by Smn deficiency in cultured
MNs. Moreover, hyperexcitability has no significant effects on
survival of WT MNs, supporting the conclusion that hyperexcit-
ability and death of Smn-deficient MNs are uncoupled events
that are mediated by different mechanisms.
DISCUSSION
The discovery that stem cells can be faithfully differentiated into
MNs has provided the foundation for modeling MN diseasesFigure 6. Smn Deficiency in INs Leads to Loss of Excitatory Synapses
(A and B) Superimposed images of VGluT2 (green) and Syp (red) immunoreactivity
in co-cultures of MNs and INs differentiated from either WT or RNAi ESCs as ind
(C) Number of VGluT2 synapses relative to all Syp+ synapses onto the soma and de
MN(RNAi) + IN(RNAi), n = 12; MN(RNAi) + IN(WT), n = 10; MN(WT) + IN(RNAi), n
(D and E) Superimposed images of VGAT (green) and Syp (red) immunoreactivity o
(F) Number of VGAT synapses relative to all Syp+ synapses onto the soma and
MN(RNAi)+IN(RNAi), n = 7. Scale bar, 10 mm (soma) and 5 mm (dendrites).
See also Figure S6.
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anisms and to identify candidate therapeutics. Here, leveraging
the power of stem cell-based approaches, we developed an
in vitro model composed of MNs and both excitatory and inhib-
itory INs in which the expression of SMN could be selectively
regulated to study the requirement for SMN in the motor cir-
cuit. Our system recapitulates key pathological events of SMA,
including degeneration and hyperexcitability of MNs. Impor-
tantly, we show that death of SMN-deficient MNs is cell auton-
omous, while MN hyperexcitability occurs through non-cell-
autonomous mechanisms involving a homeostatic response to
synaptic dysfunction of SMN-deficient excitatory INs. Together,
our findings provide insights into the cellular basis of MN
dysfunction induced by SMNdeficiency. They reveal that disrup-
ted excitatory drive alters the intrinsic physiological properties of
MNs but that membrane hyperexcitability does not trigger MN
death. Thus, dysfunction and death of MNs represent distinct
pathogenic events in the SMA motor circuit.
A hallmark of SMA is the loss of MNs, which is observed in
both patients andmousemodels of the disease (Tisdale and Pel-
lizzoni, 2015). Our findings reveal that SMN deficiency induces
selective MN death in vitro that is mediated by cell-autonomous
mechanisms. This is in agreement with previous in vitro and
in vivo studies that used stem cell-derived mouse and human
MNs (Ebert et al., 2009; Makhortova et al., 2011; Sareen et al.,
2012; Ng et al., 2015) as well as selective restoration of SMN in
MNs of SMA mice (Gogliotti et al., 2012; Martinez et al., 2012;
McGovern et al., 2015) and conditional SMN depletion from
MNs of WT mice (Park et al., 2010; McGovern et al., 2015).
Thus, our model system recapitulates a key feature of the human
disease and supports the conclusion that SMN reduction has dif-
ferential effects on the survival of MNs relative to other types
of neurons. While the precise molecular mechanisms remain to
be fully elucidated, recent work has implicated selective activa-
tion of ER stress in the death pathway of SMA MNs (Ng et al.,
2015).
SMN deficiency induces hyperexcitability of MNs in a mouse
model of SMA (Mentis et al., 2011), and this early feature of the
disease process is also observed in our stem cell model of the
motor circuit as well as in human SMA MNs differentiated from
induced pluripotent stem cells (Liu et al., 2015). Importantly,
our system allowed us to address whether MN hyperexcitability
is due to cell-autonomous or non-cell-autonomous mechanisms
induced by SMN deficiency, which was not previously estab-
lished. We found that SMN deficiency does not induce hyperex-
citability in MNs cultured in isolation but requires the presence of
INs. Moreover, SMN deficiency in premotor INs is necessary and
sufficient to increase excitability of MNs irrespective of theironto MNs
on the soma and the dendrites of a Cascade blue intracellularly filled MN (blue)
icated. Arrows indicate VGluT2 synapses.
ndrites of MNs from all four co-culture combinations: MN(WT) + IN(WT), n = 11;
= 10.
n the soma and the dendrites of MNs as in (A). Arrows indicate VGAT synapses.
dendrites of MNs from two co-culture combinations. MN(WT)+IN(WT), n = 8;
Figure 7. Block of Excitatory Neurotransmission Induces Hyperexcitability, but Not Death, of MNs
(A) Superimposed membrane responses (top traces) following current injection (bottom traces) of WT MNs in mixed cultures under different pharmacological
conditions. Graphs show current/voltage relationships for the corresponding MNs in each treatment group. The current/voltage relationship of the control MN
(blue dotted line) is included in each graph for ease of comparison. Scale bars, 20 mV, 40pA, 40ms.
(B) Mean input resistance (Rin) and time constant (t) for all experimental groups. Number of recordedMNs: control, n = 24; TTX, n = 15; ACh blockers, n = 12, Gly +
GABA blockers, n = 13, Glutamate blockers, n = 11.
(C) Survival curves of MNs for all experimental groups normalized to day 0. Data represent mean and SEM from independent experiments (n = 3).
See also Figure S7.SMN levels. Collectively, these results reveal that MN hyperex-
citability is due to non-cell-autonomous mechanisms.
Loss of glutamatergic proprioceptive synapses, but not inhib-
itory ones, is an early event that coincides with changes in the
intrinsic excitability of MNs in SMAmice (Ling et al., 2010; Mentis
et al., 2011), but a causal relationship between reduced excit-
atory drive and hyperexcitability of SMA MNs was not estab-
lished. Importantly, the presence of both excitatory (VGluT2)
and inhibitory (VGAT and GlyT2) INs allowed us to probe this
question and the underlying mechanisms responsible for thenon-autonomous effects of SMN deficiency on MN hyperexcit-
ability. Similar to observations made in SMA mice (Ling et al.,
2010), we found that VGluT2+ synapses from excitatory premo-
tor INs ontoMNs are selectively lost under SMNdeficiency, while
inhibitory synapses are not affected. Further, we show that loss
of excitatory synapses is a direct consequence of the effects of
SMN deficiency in excitatory INs. Consistent with a reduction
of excitatory drive being causally related to MN dysfunction
under SMN deficiency, chronic pharmacological blockade of
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significantly increased MN excitability, and a similar result was
obtained in experiments in which synaptic activity was abolished
by exposure to TTX. Collectively, these results indicate that SMN
deficiency results in MN dysfunction via non-cell-autonomous
mechanisms and identified excitatory INs as key determinants
of MN excitability.
Dysfunction of INs has been implicated in Alzheimer’s disease
(Palop and Mucke, 2010), schizophrenia (O’Donnell, 2012; Si-
gurdsson, 2015), and autism (Port et al., 2014; Uhlhaas and
Singer, 2012; Zoghbi and Bear, 2012). Our findings implicate
disruption of excitatory drive from premotor INs in the functional
alterations induced by SMN deficiency in the mammalian motor
circuit and identify hyperexcitability of SMN-deficient MNs as
a homeostatic response to defective glutamatergic neurotrans-
mission. Since experience refines the properties of neural cir-
cuits via activity-dependent alterations in the number, strength,
and type of synapses (Ganguly and Poo, 2013; Yin and Yuan,
2015), an imbalance of inhibitory and excitatory synaptic activity
on MNs would likely impact their intrinsic membrane properties.
The intrinsic membrane properties of MNs determine how
converging premotor synaptic drive is translated into the final
motor command transmitted to muscles (Powers and Binder,
2001). To this end, blocking synaptic activity with TTX in cultured
rat pyramidal neurons leads to increased intrinsic excitability
(Desai et al., 1999). In addition, genetic ablation of glutamatergic
synaptic transmission onto individual CA1 pyramidal neurons
in vivo causes homeostatic adaptation by strongly increasing
neuronal excitability without perturbing neuronal morphology
(Lu et al., 2013). Accordingly, we find that SMN deficiency in-
duces hyperexcitability but does not alter either soma size or
the extent of the dendritic tree of MNs. Altogether, these results
point to an indirect role for SMN in shaping the membrane excit-
ability of MNs through the control of neural network activity and
excitatory synaptic neurotransmission in the motor circuit.
Further, they support the possibility that excitatory/inhibitory
imbalance induced by SMN deficiency is an initiating event lead-
ing to the functional disruption of the SMA motor circuit.
Hyperexcitability has often been linked to neuronal death. In
a model of cerebral ischemia, selective death of hippocampal
pyramidal neurons correlated with increased input resistance
of ischemic neurons (Fan et al., 2008). Similarly, axotomy of facial
or spinal MN axons in neonatal rats causes significant loss
of MNs early after the disconnection with their muscle targets
(Mentis et al., 2007; Umemiya et al., 1993), with the marked in-
crease in input resistance of a subpopulation of axotomized
MNs being interpreted as a ‘‘pre-lethal’’ stage (Umemiya et al.,
1993). Further, changes in MN excitability have also been asso-
ciated with neuronal death in ALS (Devlin et al., 2015; Wainger
et al., 2014). Stem cell-derived ALS MNs exhibit increased firing
frequencies mediated by changes in the activity of Kv7 potas-
sium channels and reduced survival, both of which are reversed
by treatment with the Kv7 antagonist retigabine (Wainger et al.,
2014). To date, however, a cause-effect relationship between
hyperexcitability and death ofMNs has not been conclusively es-
tablished. Here, we provide direct evidence that hyperexcitabil-
ity and death of MNs are two independent, causally unrelated
events induced by SMN deficiency in the motor circuit. First,
MNs degenerate due to intrinsic, cell-autonomous mechanisms1428 Cell Reports 16, 1416–1430, August 2, 2016triggered by SMN deficiency, while MN hyperexcitability results
from dysfunction of excitatory premotor INs. Second, SMN defi-
ciency induces death of purifiedMNs in culture without changing
their intrinsic excitability. Lastly, either silencing all synaptic ac-
tivity with TTX or selectively blocking glutamatergic transmission
increases excitability of WT MNs without inducing their death.
Thus, our work reveals that hyperexcitability is not in itself a
trigger of MN death. On the contrary, we believe it reflects a
homeostatic attempt of MNs to counteract the decrease in the
excitatory drive received from premotor INs. According to this
scenario, and consistent with findings in a Drosophila SMA
model (Imlach et al., 2012; Lotti et al., 2012), correction of the
functional properties of MNs in mouse models of SMA will likely
require SMN restoration in glutamatergic neurons of the motor
circuit. Direct support of this possibility—further corroborating
the predictive power of findings in our in vitro model with regard
to the in vivo situation—comes from studies in a mouse model of
SMA, in which we find that selective restoration of SMN in gluta-
matergic neurons that provide direct excitatory drive onto MNs
is sufficient to non-autonomously reinstate the normal physio-
logical properties of SMA MNs, but not to rescue their survival
(Emily Fletcher and G.Z.M., unpublished data). By extension,
complete correction of motor function in SMA mice would
require SMN restoration in excitatory neurons of themotor circuit
in addition to MNs.
In conclusion, our findings point to premotor excitatory synap-
ses as key determinants of MN dysfunction induced by SMN
deficiency in the motor circuit and candidate therapeutic targets
for SMA. Further, our stem cell-based model of the motor circuit
provides a powerful platform to dissect the cascade of SMN-
dependent events leading to death and dysfunction of MNs at
the synaptic and molecular levels.
EXPERIMENTAL PROCEDURES
ESC Lines and Neuronal Differentiation
ESC lines were generated through lentiviral transduction (Lotti et al., 2012).
Directed differentiation of ESCs into MNs and INs was carried out according
to previously reported protocols (Wichterle et al., 2002). Further details are
provided in Supplemental Experimental Procedures.
RNA and Protein Analysis
Total RNA purification and qRT-PCR analysis were carried out as previously
described (Lotti et al., 2012). The primers used are listed in Table S2. Total pro-
tein extracts were prepared by homogenization of cells in SDS sample buffer
and analyzed by western blot using the antibodies listed in Table S3.
MN Survival
For each independent experiment, whole-well automated image acquisition
(600 ms exposure) of GFP+ MNs plated in six replicate wells of 96-well plates
per condition was performed using the Flash Cytometer (Trophos) every day
from 12 hr post-plating (0 DIV) until day 5 (5 DIV) using excitation at 455–
490 nm and emission at 495–540 nm. Cell number in each well was measured
using the MetaMorph Neurite Outgrowth Application Module (Molecular De-
vices) and the average of the six replicate wells determined.
Electrophysiology
MNs were visually targeted by their endogenous GFP fluorescence. We
applied standard whole-cell patch-current clamp protocols and recordings
were accepted for analysis only if they met the following criteria: (1) stable
resting membrane potential of 35 mV or lower and (2) overshooting action
potentials. The passive membrane properties of MNs were assessed by injec-
tion of negative and positive steps of current pulses (100 ms duration)
at 60 mV holding membrane potential. The input resistance was calculated
from the slope of the linear current/voltage relationship.
For pharmacological experiments, TTX (1mM) was added to neuronal
cultures and supplemented fresh every day for 5 days. Specific neuro-
transmitter receptor blockade was accomplished by using glutamatergic
(100 mM APV and 20 mM NBQX), GABAergic (20 mM bicuculine), glycinergic
(1 mM strychnine), and cholinergic (50 mM dihydro-b-erythroidine hydro-
bromide, 50 mM mecamylamine, and 5 mM atropine) receptor blockers.
Medium was changed every day for 5 days. Pharmacological blockers
were maintained at the same concentration during electrophysiological
experiments.
Neuronal Reconstructions
Quantification of dendritic tree length, surface area, and complexity was done
by manual tracing from single-plane confocal images of intracellularly filled
MNs using Neurolucida (v10.0, MBF Bioscience). Immunofluorescence anal-
ysis and confocal imaging was carried out as described in Supplemental
Experimental Procedures.
Statistical Analysis
Statistical analysis was carried out using the two-tailed unpaired Student’s
t test or one- or two-way ANOVA, as applicable, using Prism 5 software
(GraphPad). Data are presented as mean and SEM from independent experi-
ments, and p values are indicated as follows: *, p < 0.05; **, p < 0.01; and ***,
p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.06.087.
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